Intranasal Vasopressin Decreases Voluntary Ethanol Drinking in Single- and Group-Housed Mice Through Mechanisms Involving Vasopressin 1a and 1b Receptors. [PDF]
Alcohol Clin Exp Res (Hoboken)Nipper MA +3 more
europepmc +1 more source
Peptide Hormones in Appetite Regulation: A Complex Network. [PDF]
Pharmaceuticals (Basel)Abdollahi S, Adam H, Al Musaimi O.
europepmc +1 more source
Treatment of Refractory Syndrome of Inappropriate Antidiuresis With Sodium-Glucose Cotransporter-2 Inhibitor. [PDF]
AACE Endocrinol DiabetesChan N, Gosmanov AR.
europepmc +1 more source
Hyponatremia and Abdominal Pain: A Case Report of Acute Hepatic Porphyria. [PDF]
CureusRoldão M +4 more
europepmc +1 more source
Endocrinology and the Lung: Exploring the Bidirectional Axis and Future Directions. [PDF]
J Clin MedIglesias P.
europepmc +1 more source
Arginine vasopressin (AVP) and treatment with arginine vasopressin receptor antagonists (vaptans) in congestive heart failure, liver cirrhosis and syndrome of inappropriate antidiuretic hormone secretion (SIADH) [PDF]
European Journal of Clinical Pharmacology, 2011 Arginine vasopressin (AVP) is the major physiological regulator of renal water excretion and blood volume. The AVP pathways of V(1a)R-mediated vasoconstriction and V(2)R-induced water retention represent a potentially attractive target of therapy for edematous diseases.
Uwe Fuhr, Fikret Er, Amir M Nia
exaly +5 more sources
Related searches:
Vasopressin V2 receptor antagonists for the syndrome of inappropriate antidiuretic hormone secretion
International Urology and Nephrology, 2023Masayuki Tanemoto
exaly +3 more sources
ObjectiveThe syndrome of inappropriate secretion of antidiuretic hormone is a rare disorder in dogs characterised by hypo‐osmolality and persistent arginine vasopressin production in the absence of hypovolaemia and/or hypotension. The study describes the efficacy and safety of the nonpeptide selective arginine vasopressin V2receptor antagonist OPC ...
Fleeman, LM +3 more
openaire +5 more sources